Infensa Bioscience selected as a finalist for the 2024 KE Select Emerging Innovator Award by Life Sciences Queensland

Previous
Previous

Infensa wins KE Select Emerging Innovator of the Year at Life Sciences Queensland awards

Next
Next

Infensa CSO and co-founder Professor Glenn King elected a Fellow of the Australian Academy of Science